Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following

Antonio Abbate1, Benjamin W Van Tassell, Ignacio M Seropian

  • 1Division of Cardiology/VCU Pauley Heart Center, Virginia Commonwealth University, 1200 East Broad Street, Richmond, VA 23298-0281, USA. aabbate@mcvh-vcu.edu

Abstract

No abstract available in PubMed .

Related Concept Videos